Wednesday, February 8, 2023

BOSTON-BASED VALO HEALTH, WHICH ANALYZES CLINICAL DATA TO IDENTIFY MOLECULES AND PREDICT THEIR CHANCES FOR USE IN DRUGS, RAISES $300M SERIES B (DANIEL MCCOY/WICHITA BUSINESS JOURNAL)

Daniel McCoy / Wichita Business Journal:

Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B  —  A Boston-based company working to improve the way drugs are brought to the market has secured $110 million in Series B funding from Koch Disruptive Technologies.

Source

guestpostbloggingwork

lifesay

,valo health 300m seriesmccoy businessjournal ,bostonbased valo health 300m seriesmccoy businessjournal ,bostonbased health 300m seriesmccoy businessjournal ,health 300m seriesmccoy businessjournal ,valo health 300m wichita businessjournal ,valo health 300m seriesmccoy wichita businessjournal ,bostonbased valo health wichita businessjournal ,bostonbased valo health 300m wichita businessjournal ,bostonbased valo health seriesmccoy businessjournal ,bostonbased health 300m wichita businessjournal ,bostonbased valo health 300m wichita ,300m wichita businessjournal ,bostonbased health seriesmccoy wichita ,valo health 300m businessjournal ,health 300m seriesmccoy wichita ,bostonbased 300m seriesmccoy businessjournal ,valo 300m seriesmccoy businessjournal ,bostonbased 300m wichita businessjournal

Related Post

Latest Post